Cargando…

Neuromuscular Involvement in COVID-19 Patients

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680881/ https://www.ncbi.nlm.nih.gov/pubmed/35002141 http://dx.doi.org/10.4103/aian.AIAN_565_20

Ejemplares similares

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
por: Finsterer, Josef
Publicado: (2019)

Psychiatric abnormalities in COVID-19 patients should prompt work-up for neuro-COVID
por: Finsterer, Josef
Publicado: (2023)

Neurological complications of COVID-19 in pediatric patients require comprehensive evaluation
por: Finsterer, Josef
Publicado: (2022)

The spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad
por: Finsterer, Josef
Publicado: (2021)

Anti-mitochondrial antibody–mediated myopathy with cardiac involvement
por: Finsterer, Josef
Publicado: (2023)

Comprehensive work-up is warranted for patients with severe COVID-19 and muscle weakness including respiratory muscles
por: Finsterer, Josef
Publicado: (2021)

COVID-19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2021)

The Broad Spectrum of Neuro-Radiological Abnormalities in Patients Infected with SARS-CoV-2 Supports the Diagnosis of Neuro-COVID-19
por: Finsterer, Josef
Publicado: (2022)

Comments on: Neuro-ophthalmic presentation of COVID-19 disease: A case report
por: Finsterer, Josef
Publicado: (2021)

Do not misjudge the neurological nature of psychiatric symptoms following COVID-19 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Neuro-COVID is a serious complication of SARS-CoV-2 infections and can determine the long-term outcome of COVID-19
por: Finsterer, Josef
Publicado: (2022)

Letter to the Editor: “Impact of autopsy on clarification of the cause of death in pediatric COVID-19 fatalities”
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
por: Finsterer, Josef
Publicado: (2021)

Rule Out Alternative Causes Before Attributing Acute, Haemorrhagic, Leukoencephalitis (AHLE) to COVID-19
por: Finsterer, Josef
Publicado: (2022)

SARS‐CoV‐2‐related polyradiculitis must be preceded by PCR‐confirmed COVID‐19
por: Finsterer, Josef
Publicado: (2023)

Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”
por: Finsterer, Josef
Publicado: (2023)

Takotsubo Syndrome in COVID-19 Requires Elucidation of the Pathophysiological Background
por: Finsterer, Josef, et al.
Publicado: (2022)

Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity
por: Stollberger, Claudia, et al.
Publicado: (2015)

Gastrointestinal Involvement in m.3243A>G-associated MELAS
por: Finsterer, Josef, et al.
Publicado: (2017)

Pituitary apoplexy is not uncommon in pediatric patients and can be a manifestation of neuro-COVID
por: Finsterer, Josef
Publicado: (2023)

Letter to the Editor Regarding ‘A neonatal case of cerebral venous sinus thrombosis with intrauterine onset after COVID19 infection during pregnancy: cause or coincidence?’
por: Finsterer, Josef
Publicado: (2023)

Comparing Neuro-COVID-19 between Waves Requires Clear Cohort Selection
por: Finsterer, Josef, et al.
Publicado: (2023)

Impact of Tele-Neuromuscular Clinic on the Accessibility of Care for Patients with Inherited Neuromuscular Disorders during COVID-19 Pandemic in India
por: Reyaz, Alisha, et al.
Publicado: (2022)

Putative mechanisms explaining neuro-COVID
por: Finsterer, Josef
Publicado: (2021)

Sedation, narcotic and neuromuscular blockade in mechanically ventilated patients with COVID-19
por: Rizvi, Ghazi, et al.
Publicado: (2021)

Respiratory management for patients with neuromuscular disorders during the COVID-19 pandemic
por: Chen, Tai-Heng, et al.
Publicado: (2020)

Presentation of Neuro-COVID is Broad and Pathogenesis Diverse
por: Finsterer, Josef
Publicado: (2021)

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)

Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19
por: Finsterer, Josef, et al.
Publicado: (2022)

The Spectrum of Neuro-COVID is Broader than Frequently Anticipated
por: Finsterer, Josef
Publicado: (2023)

Telemedicine for neuromuscular disorders during the COVID-19 outbreak
por: Garibaldi, Matteo, et al.
Publicado: (2020)

Imaging abnormalities in pediatric neuro-COVID are more diverse than specified
por: Finsterer, Josef
Publicado: (2022)

Genotype–Phenotype Correlations in MPAN Due to C19orf12 Variants
por: Finsterer, Josef
Publicado: (2021)

Metabolomics by magnetic resonance spectroscopy may not sufficiently explain “brain fog” in neuro-COVID
por: Finsterer, Josef
Publicado: (2022)

Assessing beneficial or side effects of COVID-vaccinations requires personal rather than electronic investigations
por: Finsterer, Josef
Publicado: (2022)

Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome
por: Finsterer, Josef, et al.
Publicado: (2018)

Before blaming a COVID vaccine for cytotoxic lesions of the corpus callosum all other differentials must be ruled out
por: Finsterer, Josef
Publicado: (2022)

Neuro-COVID is not at variance between children and adults
por: Finsterer, Josef, et al.
Publicado: (2022)

Assessing the anesthetic effectiveness of remimazolam in MELAS patients requires careful investigations
por: Finsterer, Josef
Publicado: (2022)

Musculoskeletal complications of COVID-19 can contribute to its morbidity and mortality
por: Finsterer, Josef, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i8rsvp2t75k0nr82rts5qm9tmp